The Value of Ct-Based Radiomics in Evaluating the Response of Bone Metastases to Systemic Drug Therapy in Breast Cancer Patients

Author(s)

ABSTRACT WITHDRAWN

OBJECTIVES: To investigate the value of unenhanced CT-based radiomics in determining whether bone metastases have progressed in breast cancer patients.

METHODS: After 2-3 cycles of drug treatment, unenhanced CT was performed in 134 patients with bone metastasis of breast cancer from 3 different hospitals. According to whether the disease progressed or not, the images were divided into invalid group and valid group. The maximum cross-section of the largest osteolytic lesions in CT images was used as the region of interest (ROI) for feature extraction. Variance threshold, SelectKBest and least absolute shrinkage and selection operator (LASSO) were used to reduce the dimension of features. On this basis, the K- nearest neighbor algorithm (KNN), support vector machine (SVM), eXtreme Gradient Boosting (XGBoost), Random Forest (RF), Logistic Regression (LR) and Decision Tree (DT) were trained to establish radiomics models. Finally, the receiver operating characteristic (ROC) curves were generated to determine the diagnostic performance of various models.

RESULTS: The KNN classifier demonstrated a more optimal performance compared to other models The areas under the ROC curve (AUC) in validation set was 0.810.

CONCLUSIONS: The radiomics provides a new idea for evaluating the efficacy of patients with bone metastases, KNN model has the best performance.

Conference/Value in Health Info

2023-05, ISPOR 2023, Boston, MA, USA

Value in Health, Volume 26, Issue 6, S2 (June 2023)

Code

MSR97

Topic

Methodological & Statistical Research

Topic Subcategory

Artificial Intelligence, Machine Learning, Predictive Analytics

Disease

Oncology, Personalized & Precision Medicine

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×